Updated July 2026 · 8 min read

Propofol Infusion Syndrome for ICU Nurses 2026 — When the Sedative Starts Poisoning the Cell

Part of the ICU Pharmacology Hub — browse every related guide in one place.

Propofol is the sedative we trust the most: it goes on and off in seconds, it keeps the ventilated patient comfortable, and we titrate it hour after hour without a second thought. But there is a rare complication that turns this workhorse drug into a poison — propofol infusion syndrome, or PRIS — and it does not announce itself with an allergic reaction or an obvious event. It creeps in through the numbers on your flowsheet: a lactate that keeps climbing, a base deficit that will not correct, a heart rate that starts doing strange things. Because PRIS is driven by dose and duration, and because the nurse is the one who sees those trends first, recognizing the early pattern is very much a bedside nursing skill.

Why a familiar drug becomes toxic

The best current understanding is that propofol, at high doses over long periods, interferes with the mitochondria — the tiny power plants inside every cell. Specifically, it impairs the cell's ability to move fatty acids into the mitochondria and burn them for fuel. When cells cannot make energy the normal aerobic way, they fall back on anaerobic metabolism, which floods the body with lactic acid. At the same time, the fats the body cannot process pile up in the blood (giving the telltale high triglycerides and sometimes visibly lipemic serum), and the energy-starved muscle cells — including heart muscle — begin to break down and die. That single mechanism explains the whole clinical picture: the lactic acidosis, the muscle breakdown, the fat in the blood, and the failing heart are all downstream of a cell that can no longer make energy.

The picture that should make you think PRIS

PRIS rarely arrives as one dramatic event. It builds over hours to days in a patient who has been on a substantial propofol drip, and its signs are exactly the kind of drifting abnormalities that are easy to attribute to the underlying illness. The nurse's advantage is pattern recognition across the shift.

The combination that should raise the alarm is a patient on a high, prolonged propofol infusion who develops an unexplained metabolic acidosis together with a new bradycardia or arrhythmia. Once the cardiac signs appear, PRIS is often already advanced, so the earlier metabolic drift — the lactate that keeps ticking up despite good perfusion — is the trend worth escalating on.

Who is at higher risk

PRIS is a dose-and-duration disease first: the classic teaching is that risk rises meaningfully above roughly 4 mg/kg/hr sustained for more than 48 hours, though it has been reported at lower doses and shorter times. Beyond the drip itself, the vulnerable patients are the critically ill, the young (children were where PRIS was first recognized), those with a low carbohydrate intake, and patients receiving catecholamine vasopressors or corticosteroids — the same agents that stress the body's energy machinery. Practically, that describes a large slice of any ICU, which is why the safeguard is not avoiding propofol but respecting the ceiling: when a patient needs deep, sustained sedation at high propofol rates, the team should be watching for PRIS and thinking about adding or switching to another agent rather than simply climbing the propofol dose.

The nurse's role: catch it, stop it, support it

Prevention and early detection live almost entirely at the bedside. Know your patient's propofol rate in mg/kg/hr, not just mL/hr, and flag sustained high doses to the team — a patient parked above the danger threshold for a day or more deserves a conversation about a sedation change. Track the trends that matter: the acid-base numbers, the lactate, the CK if ordered, the potassium, the urine color and output, and the heart rate and rhythm. Treat a new, unexplained metabolic acidosis or a new bradycardia in a heavily-sedated patient as a possible drug effect, not just a sign of the underlying disease, and say so out loud.

Supporting the patient after the drip comes off

Once propofol is discontinued, the patient still needs sedation, and the team will move to another agent while the metabolic storm is managed. From there the care is organ support: cardiovascular support for the failing heart (recognizing that a PRIS bradycardia can be stubbornly resistant to the usual measures), aggressive management of the metabolic acidosis and hyperkalemia, and renal protection — sometimes including continuous renal replacement therapy to clear acid, potassium, and the offending metabolites. Throughout, the nurse keeps reassessing whether the numbers are turning the right way, because improvement after stopping the drug is the reassurance that the diagnosis was right and caught in time.

The nursing bottom line

Propofol infusion syndrome is the rare cost of the sedative we rely on most: at high doses over long durations, propofol can shut down the cell's energy production, producing a lactic acidosis, muscle breakdown, fat overload, kidney injury, and a heart that slows and fails. It builds quietly on the flowsheet, so the ICU nurse's job is to know the mg/kg/hr, to treat a creeping unexplained acidosis or a new bradycardia in a deeply-sedated patient as a red flag rather than background noise, and to escalate early — because the treatment, stopping the propofol, works best before the heart is involved. Respect the dose ceiling, watch the trends, speak up, and you turn a frequently fatal syndrome into one that gets caught in time.

Related: Sedation, SATs and SBTs · Acid-base and lactic acidosis · AKI and CRRT · Dexmedetomidine as an alternative sedative

Educational content for licensed clinicians. Always follow your facility's protocol and provider orders. Not medical advice.